
Based on NIH | Does omeprazole contain soy-derived ingredients, and could it increase the risk of side effects for people with a soy allergy?
Most U.S. omeprazole capsules and ODTs do not list soy or soy lecithin, suggesting a low exposure risk for people with soy allergy. However, excipients vary by brand and lot; verify your specific product’s inactive ingredients with the label, manufacturer, or pharmacist, and monitor for allergic symptoms.
Most omeprazole products do not list soy-derived ingredients on their official labels, and soy is not a routine excipient in common U.S. formulations. [1] [2] However, excipient lists vary by manufacturer and dosage form, so it’s best to check the exact product label or consult a pharmacist if you have a soy allergy. [3] [4]
What the labels show
- Capsules (delayed‑release): Typical inactive ingredients include crospovidone, hypromellose, methacrylic acid copolymer, lactose monohydrate, silicon dioxide, talc, titanium dioxide, triethyl citrate, and gelatin in the capsule shell; some labels note possible sodium lauryl sulfate. These lists do not include soy or soy lecithin. [1] [5]
- Other capsule listings similarly show gelatin, silicon dioxide, sodium lauryl sulfate, coloring agents, and printing inks, without soy ingredients disclosed. [2] [6]
- Orally disintegrating tablets (ODTs): Inactive ingredients often include mannitol, microcrystalline cellulose, maize maltodextrin (corn‑derived), hypromellose phthalate, crospovidone, sorbitol, sucralose, sugar spheres, talc, titanium dioxide, and triethyl citrate; again, no soy is listed. [7] [8]
Does “no soy listed” mean “soy‑free”?
Not necessarily. Drug labels are required to list inactive ingredients, but they are not always required to disclose every potential food source contaminant, and excipients can change by manufacturer and lot. [9] Reactions to food-derived excipients are considered uncommon because proteins are usually minimal or absent, but they can occur in sensitive individuals or when unintended contaminants are present. [10]
Allergy risk for soy‑allergic individuals
- Based on current labels, the typical risk of soy exposure from standard omeprazole capsules or ODTs appears low because soy ingredients are not listed. [1] [7]
- Nevertheless, very rare hypersensitivity reactions to the formulation (not necessarily soy‑related) are described for omeprazole as a class, including anaphylaxis and angioedema, so vigilance is still important if you have severe allergies. [11] [12]
- If you have had previous reactions to a specific brand or if your soy allergy is severe (e.g., anaphylaxis), choosing a product with a clear, soy‑free excipient profile and confirming with the manufacturer or pharmacist is a prudent step. [10] [9]
Practical steps to minimize risk
- Check the exact National Drug Code (NDC) and read the manufacturer’s inactive ingredient list for your capsule or ODT; different generics can use different excipients. [3] [4]
- Prefer products whose published lists are detailed and stable (e.g., those listing lactose, hypromellose, methacrylic acid copolymer, gelatin, silicon dioxide, talc, and titanium dioxide, without any soy or lecithin). [1] [5]
- If you cannot confirm excipients or you are still concerned, ask your pharmacist to order a brand with a verified soy‑free ingredient list or consider a compounded omeprazole prepared without soy‑derived excipients. [9]
- Monitor for new symptoms after starting a new lot or brand hives, swelling, trouble breathing, or severe rash warrant immediate medical attention and discontinuation. [11] [12]
Bottom line
- Most commonly available omeprazole capsules and ODTs do not list soy or soy lecithin among their inactive ingredients, suggesting a low likelihood of soy exposure from standard products. [1] [7]
- Because formulations vary and rare hypersensitivity reactions to the formulation can occur, users with significant soy allergy may want to verify excipients for their specific product and consult a pharmacist or manufacturer for confirmation. [10] [9]
Related Questions
Sources
- 1.^abcdeDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
- 2.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
- 3.^abDolgencorp, LLC Omeprazole Drug Facts(dailymed.nlm.nih.gov)
- 4.^abOMEPRAZOLE tablet, orally disintegrating, delayed release(dailymed.nlm.nih.gov)
- 5.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
- 6.^↑DailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
- 7.^abcOMEPRAZOLE tablet, orally disintegrating, delayed release(dailymed.nlm.nih.gov)
- 8.^↑LEADER OMEPRAZOLE- omeprazole tablet, orally disintegrating, delayed release(dailymed.nlm.nih.gov)
- 9.^abcdExcipient choices for special populations.(pubmed.ncbi.nlm.nih.gov)
- 10.^abcPotential food allergens in medications.(pubmed.ncbi.nlm.nih.gov)
- 11.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
- 12.^abDailyMed - OMEPRAZOLE capsule, delayed release(dailymed.nlm.nih.gov)
Important Notice: This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any medical decisions.


